Notice: This company has been marked as potentially delisted and may not be actively trading. Allergy Therapeutics (AGYTF) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisHeadlinesShort Interest Allergy Therapeutics Short Interest DataAllergy Therapeutics (AGYTF) has a short interest of 200 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 0 shares to cover all short positions.Current Short Interest200 sharesPrevious Short Interest200 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$12.00Short Interest Ratio0.0 Days to CoverLast Record DateSeptember 30, 2024Outstanding Shares688,950,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume0 sharesAverage Trading Volume0 sharesToday's Volume Vs. AverageNaN Short Selling Allergy Therapeutics? Sign up to receive the latest short interest report for Allergy Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAGYTF Short Interest Over TimeAGYTF Days to Cover Over TimeAGYTF Percentage of Float Shorted Over Time Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Allergy Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/2024200 shares $12.00 No ChangeN/A0 $0.06 9/15/2024200 shares $12.00 No ChangeN/A0 $0.06 8/31/2024200 shares $12.00 No ChangeN/A0 $0.06 8/15/2024200 shares $12.00 No ChangeN/A0 $0.06 7/31/2024200 shares $12.00 No ChangeN/A0 $0.06 7/15/2024200 shares $4.00 No ChangeN/A0.2 $0.02 Get the Latest News and Ratings for AGYTF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 6/30/2024200 shares $4.00 No ChangeN/A0 $0.02 6/15/2024200 shares $4.00 No ChangeN/A0 $0.02 5/31/2024200 shares $4.00 No ChangeN/A0 $0.02 5/15/2024200 shares $4.00 No ChangeN/A0 $0.02 4/30/2024200 shares $4.00 No ChangeN/A0 $0.02 4/15/2024200 shares $4.00 No ChangeN/A0 $0.02 3/31/2024200 shares $4.00 No ChangeN/A0.2 $0.02 3/15/2024200 shares $4.00 No ChangeN/A0.1 $0.02 2/29/2024200 shares $2.00 No ChangeN/A0 $0.01 2/15/2024200 shares $2.00 No ChangeN/A0 $0.01 1/15/2024200 shares $2.00 No ChangeN/A0 $0.01 12/31/2023200 shares $2.00 No ChangeN/A0 $0.01 12/15/2023200 shares $2.00 No ChangeN/A0 $0.01 11/30/2023200 shares $2.00 No ChangeN/A0 $0.01 11/15/2023200 shares $2.00 No ChangeN/A0 $0.01 10/31/2023200 shares $2.00 No ChangeN/A0.4 $0.01 10/15/2023200 shares $35.00 No ChangeN/A0 $0.18 9/30/2023200 shares $35.00 No ChangeN/A0 $0.18 9/15/2023200 shares $35.00 No ChangeN/A0 $0.18 8/31/2023200 shares $35.00 No ChangeN/A0 $0.18 8/15/2023200 shares $35.00 No ChangeN/A0 $0.18 7/31/2023200 shares $35.00 No ChangeN/A0.1 $0.18 7/15/2023200 shares $35.00 No ChangeN/A0 $0.18 6/30/2023200 shares $35.00 -98.0%N/A0 $0.18 6/15/202310,200 shares $1,785.00 No ChangeN/A0 $0.18 5/31/202310,200 shares $1,785.00 No ChangeN/A0 $0.18 5/15/202310,200 shares $1,785.00 No ChangeN/A0 $0.18 4/30/202310,200 shares $1,785.00 No ChangeN/A0 $0.18 4/15/202310,200 shares $1,785.00 No ChangeN/A102 $0.18 3/31/202310,200 shares $510.00 No ChangeN/A102 $0.05 3/15/202310,200 shares $1,621.80 No ChangeN/A0 $0.16 2/28/202310,200 shares $1,621.80 No ChangeN/A0 $0.16 2/15/202310,200 shares $1,621.80 No ChangeN/A102 $0.16 1/31/202310,200 shares $1,621.80 No ChangeN/A0 $0.16Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW 1/15/202310,200 shares $1,621.80 +5,000.0%N/A4.6 $0.16 12/30/2022200 shares $15.40 No ChangeN/A0 $0.08 12/15/2022200 shares $31.20 No ChangeN/A0.1 $0.16 11/30/2022200 shares $30.80 No ChangeN/A0 $0.15 11/15/2022200 shares $30.80 No ChangeN/A0 $0.15 10/31/2022200 shares $48.60 No ChangeN/A0 $0.24 10/15/2022200 shares $48.60 No ChangeN/A2 $0.24 9/30/2022200 shares $48.60 No ChangeN/A2 $0.24 9/15/2022200 shares $54.00 No ChangeN/A2 $0.27 8/31/2022200 shares $54.00 No ChangeN/A0 $0.27 8/15/2022200 shares $54.00 No ChangeN/A0 $0.27 7/31/2022200 shares $54.00 No ChangeN/A0 $0.27 7/15/2022200 shares $54.00 -99.0%N/A0 $0.27 6/30/202220,200 shares $5,454.00 -58.6%N/A4 $0.27 6/15/202248,800 shares $14,976.72 +24,300.0%N/A4.1 $0.31 5/31/2022200 shares $55.30 No ChangeN/A0 $0.28 5/15/2022200 shares $55.30 No ChangeN/A2 $0.28 4/30/2022200 shares $59.60 No ChangeN/A0 $0.30 4/15/2022200 shares $69.58 No ChangeN/A1 $0.35 3/31/2022200 shares $69.58 No ChangeN/A0.3 $0.35 3/15/2022200 shares $56.80 No ChangeN/A2 $0.28 2/28/2022200 shares $88.00 No ChangeN/A0 $0.44 2/15/2022200 shares $88.00 No ChangeN/A0 $0.44 1/31/2022200 shares $88.00 No ChangeN/A0 $0.44 1/15/2022200 shares $88.00 No ChangeN/A0 $0.44 12/31/2021200 shares $88.00 -93.6%N/A2 $0.44 12/15/20213,100 shares $1,581.00 No ChangeN/A0 $0.51 11/30/20213,100 shares $1,581.00 No ChangeN/A31 $0.51 11/15/20213,100 shares $1,670.90 +1,450.0%N/A5.2 $0.54 10/29/2021200 shares $99.60 No ChangeN/A0.1 $0.50 10/15/2021200 shares $92.00 No ChangeN/A1 $0.46 9/30/2021200 shares $92.00 -33.3%N/A0.7 $0.46 9/15/2021300 shares $135.00 No ChangeN/A3 $0.45 8/31/2021300 shares $126.00 -25.0%N/A3 $0.42 8/13/2021400 shares $170.00 +100.0%N/A0.8 $0.43 7/30/2021200 shares $50.00 No ChangeN/A0.1 $0.25 9/30/2020300 shares $66.00 No ChangeN/A0.6 $0.22 9/15/2020300 shares $73.50 No ChangeN/A0.2 $0.25 4/30/202014,400 shares $2,592.00 -70.9%N/A0.3 $0.18 4/15/202049,400 shares $7,360.60 +495.2%N/A5.2 $0.15 3/31/20208,300 shares $954.50 No ChangeN/A0.4 $0.12 3/13/20208,300 shares $1,162.00 +822.2%N/A5.5 $0.14 2/28/2020900 shares $162.00 No ChangeN/A4.5 $0.18 2/14/2020900 shares $136.80 -64.0%N/A0 $0.15 1/31/20202,500 shares $380.00 No ChangeN/A5 $0.15 AGYTF Short Interest - Frequently Asked Questions What is Allergy Therapeutics' current short interest? Short interest is the volume of Allergy Therapeutics shares that have been sold short but have not yet been closed out or covered. As of September 30th, traders have sold 200 shares of AGYTF short. Learn More on Allergy Therapeutics' current short interest. How does Allergy Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "private households" compare to Allergy Therapeutics: IQE plc (0.18%), Datalex plc (0.00%), Bonterra Energy Corp. (0.99%), Petrofac Limited (0.02%), Atos SE (0.00%), Esprit Holdings Limited (0.00%), Surge Battery Metals Inc. (0.01%), Parkson Retail Group Limited (0.00%), DIAGNOS Inc. (0.03%), Cirata plc (0.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.04 billion), AppLovin Co. ($2.69 billion), Nu Holdings Ltd. ($2.64 billion), Paychex, Inc. ($2.61 billion), Cencora, Inc. ($2.30 billion), Aptiv PLC ($2.09 billion), Moderna, Inc. ($2.09 billion), Tractor Supply ($2.04 billion), Coinbase Global, Inc. ($1.97 billion), and International Paper ($1.95 billion). View all of the most shorted stocks. What does it mean to sell short Allergy Therapeutics stock? Short selling AGYTF is an investing strategy that aims to generate trading profit from Allergy Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Allergy Therapeutics? A short squeeze for Allergy Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AGYTF, which in turn drives the price of the stock up even further. How often is Allergy Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AGYTF, twice per month. The most recent reporting period available is September, 30 2024. More Short Interest Resources from MarketBeat Related Companies IQE Short Interest Datalex Short Interest Bonterra Energy Short Interest Petrofac Short Interest Atos Short Interest Esprit Short Interest Surge Battery Metals Short Interest Parkson Retail Group Short Interest DIAGNOS Short Interest Cirata Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:AGYTF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allergy Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Allergy Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AGYTF Stock Alerts